As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

Eli Lilly has unveiled a $27 billion (€25.7 billion) investment in US manufacturing facilities as the pharmaceutical industry ...

House Republicans advanced their budget framework for President Donald Trump’s sweeping domestic policy agenda late Tuesday, ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

A federal judge on Thursday refused to temporarily block the Trump administration’s mass layoff of federal workers while a ...

His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.

A meeting held between President Donald Trump and top pharmaceutical executives showed some tensions over drug pricing policy, tariffs and manufacturing.

President Donald Trump has warned a group of major U.S. drugmakers that his administration is set to impose tariffs on pharmaceutical goods, and they should start moving their manufacturing businesses ...